Brief: Heidelberg Pharma FY Sales Revenue Up By 93% To EUR 3.7 Mln

Heidelberg Pharma AG

21/03/2019 06:03

March 21 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * FY SALES REVENUE BY 93% TO EUR 3.7 MILLION (PREVIOUS YEAR: EUR 1.9 MILLION)
    * FY EARNINGS BEFORE TAX OF EUR -11.7 MILLION (PREVIOUS YEAR: EUR -11.0 MILLION)
    * FY NET LOSS FOR YEAR WAS ALSO EUR 11.7 MILLION (PREVIOUS YEAR: EUR 11.0 MILLION)
    * OUTLOOK 2019: BETWEEN EUR 5.0 MILLION AND EUR 7.0 MILLION IN SALES REVENUE AND OTHER
INCOME
    * EBIT FOR 2019 ARE PROJECTED TO BE BETWEEN EUR -8.0 MILLION AND EUR -12.0 MILLION (2018:
EUR
-11.7 MILLION)

Source text for Eikon:  ID:nEQ47wCmJa 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))